Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans

PLoS Pathogens

Volumn 7, Issue 12, 2011, Pages

  Teirlinck, Anne C ^a   McCall, Matthew B B ^a   Roestenberg, Meta ^a   Scholzen, Anja ^a   Woestenenk, Rob ^a   de Mast, Quirijn ^a   van der Ven, Andre J A M ^a   Hermsen, Cornelus C ^a   Luty, Adrian J F ^a   Sauerwein, Robert W ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD45RO ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; L SELECTIN; IL2 PROTEIN, HUMAN;

ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; LONGEVITY; LONGITUDINAL STUDY; LYMPHOCYTE; MALARIA FALCIPARUM; NATURAL KILLER CELL; NORMAL HUMAN; PHENOTYPE; PLASMODIUM FALCIPARUM; SPOROZOITE; T CELL DEPLETION; T LYMPHOCYTE; CLINICAL TRIAL; FEMALE; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MALE; PHYSIOLOGY; TIME;

PLASMODIUM FALCIPARUM;

FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; INTERLEUKIN-2; KILLER CELLS, NATURAL; LONGITUDINAL STUDIES; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; T-LYMPHOCYTES; TIME FACTORS;

EID: 84855291335     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002389     Document Type: Article

References (80)

1. World Health Organization (2008) World Malaria Report 2008. WHO/HTM/GMP/2008.1.
2. Marsh K, Kinyanjui S, (2006) Immune effector mechanisms in malaria. Parasite Immunol 28: 51-60.
3. Schofield L, Mueller I, (2006) Clinical immunity to malaria. Curr Mol Med 6: 205-221.
4. Cockburn IA, Zavala F, (2007) T cell memory in malaria. Curr Opin Immunol 19: 424-429.
5. Doolan DL, Dobano C, Baird JK, (2009) Acquired immunity to malaria. Clin Microbiol Rev 22: 13-36.
6. Struik SS, Riley EM, (2004) Does malaria suffer from lack of memory? Immunol Rev 201: 268-290.
7. Achtman AH, Bull PC, Stephens R, Langhorne J, (2005) Longevity of the immune response and memory to blood-stage malaria infection. Curr Top Microbiol Immunol 297: 71-102.
8. Migot F, Chougnet C, Raharimalala L, Astagneau P, Lepers JP, et al. (1993) Human immune responses to the Plasmodium falciparum ring-infected erythrocyte surface antigen (Pf155/RESA) after a decrease in malaria transmission in Madagascar. Am J Trop Med Hyg 48: 432-439.
9. Wipasa J, Okell L, Sakkhachornphop S, Suphavilai C, Chawansuntati K, et al. (2011) Short-lived IFN-gamma effector responses, but long-lived IL-10 memory responses, to malaria in an area of low malaria endemicity. PLoS Pathog 7: e1001281.
10. Zevering Y, Khamboonruang C, Rungruengthanakit K, Tungviboonchai L, Ruengpipattanapan J, et al. (1994) Life-spans of human T-cell responses to determinants from the circumsporozoite proteins of Plasmodium falciparum and Plasmodium vivax. Proc Natl Acad Sci USA 91: 6118-6122.
11. Bejon P, Mwacharo J, Kai O, Todryk S, Keating S, et al. (2007) The induction and persistence of T cell IFN-gamma responses after vaccination or natural exposure is suppressed by Plasmodium falciparum. J Immunol 179: 4193-4201.
12. Dent AE, Chelimo K, Sumba PO, Spring MD, Crabb BS, et al. (2009) Temporal stability of naturally acquired immunity to Merozoite Surface Protein-1 in Kenyan adults. Malar J 8: 162.
13. Flanagan KL, Mwangi T, Plebanski M, Odhiambo K, Ross A, et al. (2003) Ex vivo interferon-gamma immune response to thrombospondin-related adhesive protein in coastal Kenyans: longevity and risk of Plasmodium falciparum infection. Am J Trop Med Hyg 68: 421-430.
14. Moormann AM, Sumba PO, Tisch DJ, Embury P, King CH, et al. (2009) Stability of interferon-gamma and interleukin-10 responses to Plasmodium falciparum liver stage antigen 1 and thrombospondin-related adhesive protein immunodominant epitopes in a highland population from Western Kenya. Am J Trop Med Hyg 81: 489-495.
15. Riley EM, Morris-Jones S, Blackman MJ, Greenwood BM, Holder AA, (1993) A longitudinal study of naturally acquired cellular and humoral immune responses to a merozoite surface protein (MSP1) of Plasmodium falciparum in an area of seasonal malaria transmission. Parasite Immunol 15: 513-524.
16. Hviid L, Theander TG, Jakobsen PH, bu-Zeid YA, Abdulhadi NH, et al. (1990) Cell-mediated immune responses to soluble Plasmodium falciparum antigens in residents from an area of unstable malaria transmission in the Sudan. APMIS 98: 594-604.
17. Wyler DJ, Oppenheim JJ, (1974) Lymphocyte transformation in human Plasmodium falciparum malaria. J Immunol 113: 449-454.
18. Todryk SM, Walther M, Bejon P, Hutchings C, Thompson FM, et al. (2009) Multiple functions of human T cells generated by experimental malaria challenge. Eur J Immunol 39: 3042-3051.
19. McCall MB, Sauerwein RW, (2010) Interferon-gamma--central mediator of protective immune responses against the pre-erythrocytic and blood stage of malaria. J Leukoc Biol 88: 1131-1143.
20. Sauerwein RW, Roestenberg M, Moorthy VS, (2011) Experimental human challenge infections can accelerate clinical malaria vaccine development. Nat Rev Immunol 11: 57-64.
21. Pombo DJ, Lawrence G, Hirunpetcharat C, Rzepczyk C, Bryden M, et al. (2002) Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum. Lancet 360: 610-617.
22. Roestenberg M, Teirlinck AC, McCall MB, Teelen K, Makamdop KN, et al. (2011) Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Lancet 377: 1770-1776.
23. Roestenberg M, McCall M, Hopman J, Wiersma J, Luty AJ, v et al, (2009) Protection against a malaria challenge by sporozoite inoculation. N Engl J Med 361: 468-477.
24. Dodoo D, Omer FM, Todd J, Akanmori BD, Koram KA, et al. (2002) Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria. J Infect Dis 185: 971-979.
25. D'Ombrain MC, Robinson LJ, Stanisic DI, Taraika J, Bernard N, et al. (2008) Association of early interferon-gamma production with immunity to clinical malaria: a longitudinal study among Papua New Guinean children. Clin Infect Dis 47: 1380-1387.
26. Luty AJ, Lell B, Schmidt-Ott R, Lehman LG, Luckner D, et al. (1999) Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children. J Infect Dis 179: 980-988.
27. McCall MB, Hopman J, Daou M, Maiga B, Dara V, et al. (2010) Early interferon-gamma response against Plasmodium falciparum correlates with interethnic differences in susceptibility to parasitemia between sympatric Fulani and Dogon in Mali. J Infect Dis 201: 142-152.
28. Artavanis-Tsakonas K, Riley EM, (2002) Innate immune response to malaria: rapid induction of IFN-gamma from human NK cells by live Plasmodium falciparum-infected erythrocytes. J Immunol 169: 2956-2963.
29. Baratin M, Roetynck S, Lepolard C, Falk C, Sawadogo S, et al. (2005) Natural killer cell and macrophage cooperation in MyD88-dependent innate responses to Plasmodium falciparum. Proc Natl Acad Sci USA 102: 14747-14752.
30. McCall MB, Roestenberg M, Ploemen I, Teirlinck A, Hopman J, et al. (2010) Memory-like IFN-gamma response by NK cells following malaria infection reveals the crucial role of T cells in NK cell activation by P. falciparum. Eur J Immunol 40: 3472-3477.
31. Hensmann M, Kwiatkowski D, (2001) Cellular basis of early cytokine response to Plasmodium falciparum. Infect Immun 69: 2364-2371.
32. Waterfall M, Black A, Riley E, (1998) Gammadelta+ T cells preferentially respond to live rather than killed malaria parasites. Infect Immun 66: 2393-2398.
33. D'Ombrain MC, Hansen DS, Simpson KM, Schofield L, (2007) gammadelta-T cells expressing NK receptors predominate over NK cells and conventional T cells in the innate IFN-gamma response to Plasmodium falciparum malaria. Eur J Immunol 37: 1864-1873.
34. Currier J, Sattabongkot J, Good MF, (1992) 'Natural' T cells responsive to malaria: evidence implicating immunological cross-reactivity in the maintenance of TCR alpha beta+ malaria-specific responses from non-exposed donors. Int Immunol 4: 985-994.
35. Zevering Y, Amante F, Smillie A, Currier J, Smith G, et al. (1992) High frequency of malaria-specific T cells in non-exposed humans. Eur J Immunol 22: 689-696.
36. Roussilhon C, Agrapart M, Guglielmi P, Bensussan A, Brasseur P, et al. (1994) Human TcR gamma delta+ lymphocyte response on primary exposure to Plasmodium falciparum. Clin Exp Immunol 95: 91-97.
37. Rzepczyk CM, Stamatiou S, Anderson K, Stowers A, Cheng Q, et al. (1996) Experimental human Plasmodium falciparum infections: longitudinal analysis of lymphocyte responses with particular reference to gamma delta T cells. Scand J Immunol 43: 219-227.
38. Hviid L, Kurtzhals JA, Dodoo D, Rodrigues O, Ronn A, et al. (1996) The gamma/delta T-cell response to Plasmodium falciparum malaria in a population in which malaria is endemic. Infect Immun 64: 4359-4362.
39. Behr C, Dubois P, (1992) Preferential expansion of V gamma 9 V delta 2 T cells following stimulation of peripheral blood lymphocytes with extracts of Plasmodium falciparum. Int Immunol 4: 361-366.
40. Behr C, Poupot R, Peyrat MA, Poquet Y, Constant P, et al. (1996) Plasmodium falciparum stimuli for human gammadelta T cells are related to phosphorylated antigens of mycobacteria. Infect Immun 64: 2892-2896.
41. Horowitz A, Newman KC, Evans JH, Korbel DS, Davis DM, et al. (2010) Cross-talk between T cells and NK cells generates rapid effector responses to Plasmodium falciparum-infected erythrocytes. J Immunol 184: 6043-6052.
42. Jung TM, Gallatin WM, Weissman IL, Dailey MO, (1988) Down-regulation of homing receptors after T cell activation. J Immunol 141: 4110-4117.
43. Sallusto F, Geginat J, Lanzavecchia A, (2004) Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 22: 745-763.
44. Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, et al. (2007) Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 13: 843-850.
45. Bejon P, Keating S, Mwacharo J, Kai OK, Dunachie S, et al. (2006) Early gamma interferon and interleukin-2 responses to vaccination predict the late resting memory in malaria-naive and malaria-exposed individuals. Infect Immun 74: 6331-6338.
46. Seder RA, Darrah PA, Roederer M, (2008) T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol 8: 247-258.
47. Chizzolini C, Grau GE, Geinoz A, Schrijvers D, (1990) T lymphocyte interferon-gamma production induced by Plasmodium falciparum antigen is high in recently infected non-immune and low in immune subjects. Clin Exp Immunol 79: 95-99.
48. Rhee MS, Akanmori BD, Waterfall M, Riley EM, (2001) Changes in cytokine production associated with acquired immunity to Plasmodium falciparum malaria. Clin Exp Immunol 126: 503-510.
49. Ocana-Morgner C, Mota MM, Rodriguez A, (2003) Malaria blood stage suppression of liver stage immunity by dendritic cells. J Exp Med 197: 143-151.
50. Kemp K, Akanmori BD, Adabayeri V, Goka BQ, Kurtzhals JA, et al. (2002) Cytokine production and apoptosis among T cells from patients under treatment for Plasmodium falciparum malaria. Clin Exp Immunol 127: 151-157.
51. Riccio EK, Junior IN, Riccio LR, das Gracas AM, Corte-Real S, et al. (2003) Malaria associated apoptosis is not significantly correlated with either parasitemia or the number of previous malaria attacks. Parasitol Res 90: 9-18.
52. Otoo LN, Riley EM, Menon A, Byass P, Greenwood BM, (1989) Cellular immune responses to Plasmodium falciparum antigens in children receiving long term anti-malarial chemoprophylaxis. Trans R Soc Trop Med Hyg 83: 778-782.
53. Brustoski K, Moller U, Kramer M, Hartgers FC, Kremsner PG, et al. (2006) Reduced cord blood immune effector-cell responsiveness mediated by CD4+ cells induced in utero as a consequence of placental Plasmodium falciparum infection. J Infect Dis 193: 146-154.
54. Finney OC, Nwakanma D, Conway DJ, Walther M, Riley EM, (2009) Homeostatic regulation of T effector to Treg ratios in an area of seasonal malaria transmission. Eur J Immunol 39: 1288-1300.
55. Torcia MG, Santarlasci V, Cosmi L, Clemente A, Maggi L, et al. (2008) Functional deficit of T regulatory cells in Fulani, an ethnic group with low susceptibility to Plasmodium falciparum malaria. Proc Natl Acad Sci USA 105: 646-651.
56. Walther M, Tongren JE, Andrews L, Korbel D, King E, et al. (2005) Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection. Immunity 23: 287-296.
57. Baird JK, (1998) Age-dependent characteristics of protection v. susceptibility to Plasmodium falciparum. Ann Trop Med Parasitol 92: 367-390.
58. Schaible UE, Kaufmann SH, (2007) Malnutrition and infection: complex mechanisms and global impacts. PLoS Med 4: e115.
59. Hartgers FC, Obeng BB, Kruize YC, Dijkhuis A, McCall M, et al. (2009) Responses to malarial antigens are altered in helminth-infected children. J Infect Dis 199: 1528-1535.
60. Wammes LJ, Hamid F, Wiria AE, de GB, Sartono E, et al. (2010) Regulatory T cells in human geohelminth infection suppress immune responses to BCG and Plasmodium falciparum. Eur J Immunol 40: 437-442.
61. Siegrist CA, (2001) Neonatal and early life vaccinology. Vaccine 19: 3331-3346.
62. Zola H, (1997) The development of antibody responses in the infant. Immunol Cell Biol 75: 587-590.
63. Broen K, Brustoski K, Engelmann I, Luty AJ, (2007) Placental Plasmodium falciparum infection: causes and consequences of in utero sensitization to parasite antigens. Mol Biochem Parasitol 151: 1-8.
64. Bucci K, Kastens W, Hollingdale MR, Shankar A, Alpers MP, et al. (2000) Influence of age and HLA type on interferon-gamma (IFN-gamma) responses to a naturally occurring polymorphic epitope of Plasmodium falciparum liver stage antigen-1 (LSA-1). Clin Exp Immunol 122: 94-100.
65. John CC, Moormann AM, Sumba PO, Ofulla AV, Pregibon DC, et al. (2004) Gamma interferon responses to Plasmodium falciparum liver-stage antigen 1 and thrombospondin-related adhesive protein and their relationship to age, transmission intensity, and protection against malaria. Infect Immun 72: 5135-5142.
66. Ramharter M, Winkler H, Kremsner PG, Adegnika AA, Willheim M, et al. (2005) Age-dependency of Plasmodium falciparum-specific and non-specific T cell cytokine responses in individuals from a malaria-endemic area. Eur Cytokine Netw 16: 135-143.
67. Winkler S, Willheim M, Baier K, Schmid D, Aichelburg A, et al. (1999) Frequency of cytokine-producing T cells in patients of different age groups with Plasmodium falciparum malaria. J Infect Dis 179: 209-216.
68. Kidgell C, Volkman SK, Daily J, Borevitz JO, Plouffe D, et al. (2006) A systematic map of genetic variation in Plasmodium falciparum. PLoS Pathog 2: e57.
69. Sauerwein RW, Bijker EM, Richie TL, (2010) Empowering malaria vaccination by drug administration. Curr Opin Immunol 22: 367-373 S0952-7915(10)00065-8 [pii];10.1016/j.coi.2010.04.001 [doi].
70. Rivadeneira EM, Wasserman M, Espinal CT, (1983) Separation and concentration of schizonts of Plasmodium falciparum by Percoll gradients. J Protozool 30: 367-370.
71. Ponnudurai T, Lensen AH, van Gemert GJ, Bensink MP, Bolmer M, et al. (1989) Infectivity of cultured Plasmodium falciparum gametocytes to mosquitoes. Parasitology 98 Pt 2: 165-173.
72. Stewart MJ, Vanderberg JP, (1988) Malaria sporozoites leave behind trails of circumsporozoite protein during gliding motility. J Protozool 35: 389-393.
73. Verhage DF, Telgt DS, Bousema JT, Hermsen CC, van Gemert GJ, v et al, (2005) Clinical outcome of experimental human malaria induced by Plasmodium falciparum-infected mosquitoes. Neth J Med 63: 52-58.
74. Nardin EH, Oliveira GA, Calvo-Calle JM, Wetzel K, Maier C, et al. (2004) Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes. Infect Immun 72: 6519-6527.
75. Flueck C, Frank G, Smith T, Jafarshad A, Nebie I, et al. (2009) Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates. Vaccine 27: 2653-2661.
76. Meraldi V, Nebie I, Moret R, Cuzin-Ouattara N, Thiocone A, et al. (2002) Recognition of synthetic polypeptides corresponding to the N- and C-terminal fragments of Plasmodium falciparum Exp-1 by T-cells and plasma from human donors from African endemic areas. Parasite Immunol 24: 141-150.
77. Audran R, Cachat M, Lurati F, Soe S, Leroy O, et al. (2005) Phase I malaria vaccine trial with a long synthetic peptide derived from the merozoite surface protein 3 antigen. Infect Immun 73: 8017-8026.
78. Hermsen CC, Verhage DF, Telgt DS, Teelen K, Bousema JT, et al. (2007) Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial. Vaccine 25: 2930-2940.
79. Hillier CJ, Ware LA, Barbosa A, Angov E, Lyon JA, et al. (2005) Process development and analysis of liver-stage antigen 1, a preerythrocyte-stage protein-based vaccine for Plasmodium falciparum. Infect Immun 73: 2109-2115.
80. Roestenberg M, Remarque E, de JE, Hermsen R, Blythman H, et al. (2008) Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1 malaria vaccine adjuvanted with Alhydrogel, Montanide ISA 720 or AS02. PLoS One 3: e3960.